Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1987-9-21
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0300-9750
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
281
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
305-11
|
pubmed:dateRevised |
2008-2-12
|
pubmed:meshHeading |
pubmed-meshheading:2441553-Antithyroid Agents,
pubmed-meshheading:2441553-Graves Disease,
pubmed-meshheading:2441553-Humans,
pubmed-meshheading:2441553-Methimazole,
pubmed-meshheading:2441553-Models, Biological,
pubmed-meshheading:2441553-Thyroid Gland,
pubmed-meshheading:2441553-Thyroiditis, Autoimmune
|
pubmed:year |
1987
|
pubmed:articleTitle |
Thyrostatic drugs act through modulation of thyroid cell activity to induce remissions in Graves' disease.
|
pubmed:publicationType |
Journal Article
|